What is the recommended treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cellulitis

The recommended first-line treatment for typical non-purulent cellulitis is a 5-day course of an antibiotic active against streptococci, such as penicillin, amoxicillin, dicloxacillin, cephalexin, or clindamycin. 1, 2

Assessment and Classification

  • Assess for systemic signs of infection to determine severity and appropriate treatment setting 1
  • Cellulitis is a diffuse, superficial, spreading skin infection characterized by rapidly spreading areas of erythema, swelling, tenderness, and warmth 3
  • Cultures of blood or cutaneous aspirates are not routinely recommended for typical cases of cellulitis 1, 3
  • Blood cultures should be obtained for patients with malignancy, severe systemic features, or unusual predisposing factors 1, 3

Antibiotic Selection Based on Severity

Mild Non-purulent Cellulitis

  • Use antibiotics active against streptococci (the most common causative organisms) 1, 4:
    • Penicillin
    • Amoxicillin
    • Dicloxacillin
    • Cephalexin (500 mg four times daily)
    • Clindamycin 1, 2

Moderate to Severe Non-purulent Cellulitis

  • Consider coverage for both streptococci and methicillin-susceptible S. aureus (MSSA) 1
  • For patients with systemic signs of infection, many clinicians include coverage against MSSA 3
  • For severe infections, vancomycin plus either piperacillin-tazobactam or imipenem-meropenem is recommended as a reasonable empiric regimen 3

MRSA Considerations

  • MRSA is an unusual cause of typical cellulitis, and treatment specifically targeting MRSA is usually unnecessary 2
  • Consider MRSA coverage only in specific situations:
    • Cellulitis associated with penetrating trauma
    • Evidence of MRSA infection elsewhere
    • Nasal colonization with MRSA
    • Injection drug use
    • Purulent drainage
    • Systemic inflammatory response syndrome (SIRS) 2, 3

Duration of Treatment

  • A 5-day course of antimicrobial therapy is recommended for uncomplicated cellulitis 1, 2
  • Treatment should be extended if the infection has not improved within 5 days 1, 3
  • Studies have shown that a 5-day course is as effective as a 10-day course if clinical improvement occurs by day 5 2, 3

Treatment Setting

  • Outpatient therapy is recommended for patients without SIRS, altered mental status, or hemodynamic instability 1, 3
  • Hospitalization is recommended for patients with:
    • Concern for deeper or necrotizing infection
    • Poor adherence to therapy
    • Severe immunocompromise
    • Failing outpatient treatment 1, 3

Adjunctive Measures

  • Elevation of the affected area to promote gravity drainage of edema and inflammatory substances 1, 2
  • Treatment of predisposing factors such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 1
  • Consider systemic corticosteroids in non-diabetic adult patients to reduce inflammation and hasten resolution 2
  • Some evidence suggests that adding anti-inflammatory therapy (such as ibuprofen) to antibiotic treatment may hasten resolution of cellulitis-related inflammation 5

Prevention of Recurrence

  • Identify and treat predisposing conditions such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 1
  • In lower extremity cellulitis, carefully examine the interdigital toe spaces and treat fissuring, scaling, or maceration to reduce recurrence 3
  • For patients with 3-4 episodes of cellulitis per year despite treatment of predisposing factors, consider prophylactic antibiotics 1

Common Pitfalls to Avoid

  • Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred 2
  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors 2, 3
  • Don't confuse cellulitis with cutaneous inflammation associated with collections of pus (such as septic bursitis, furuncles, or skin abscesses), which primarily require drainage rather than antibiotics 3
  • Don't overlook underlying conditions that may predispose to recurrent cellulitis 6

References

Guideline

Treatment of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Finger Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Research

Cellulitis.

Infectious disease clinics of North America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.